🇪🇺 Zometa in European Union

EMA authorised Zometa on 20 March 2001

Marketing authorisation

EMA — authorised 20 March 2001

  • Status: approved

Zometa in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Zometa approved in European Union?

Yes. EMA authorised it on 20 March 2001.

Who is the marketing authorisation holder for Zometa in European Union?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.